These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28496968)

  • 21. Drug shortages: searching for a cure.
    Gagnon MA
    Healthc Policy; 2012 May; 7(4):10-7. PubMed ID: 23634158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Support of public-private partnerships in health promotion and conflicts of interest.
    Hernandez-Aguado I; Zaragoza GA
    BMJ Open; 2016 Apr; 6(4):e009342. PubMed ID: 27091816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving health with partnerships between academia and industry.
    Desmond-Hellmann S
    JAMA Intern Med; 2013 Jun; 173(12):1051-2. PubMed ID: 23609423
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenges for pharmaceutical industry: new partnerships for sustainable human health.
    Hunter J
    Philos Trans A Math Phys Eng Sci; 2011 May; 369(1942):1817-25. PubMed ID: 21464073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 28. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precarious connections: making therapeutic production happen for malaria and tuberculosis.
    Craddock S
    Soc Sci Med; 2015 Mar; 129():36-43. PubMed ID: 25142906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to create a public-private partnership: a replicable project associated with business continuity.
    Hahn D
    J Bus Contin Emer Plan; 2010 Jul; 4(3):274-85. PubMed ID: 20826390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reforms are needed to increase public funding and curb demand for private care in Israel's health system.
    Chernichovsky D
    Health Aff (Millwood); 2013 Apr; 32(4):724-33. PubMed ID: 23569052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Driving Local Health Departments' Partnerships With Other Organizations in Maternal and Child Health, Communicable Disease Prevention, and Chronic Disease Control.
    Luo H; Winterbauer NL; Shah G; Tucker A; Xu L
    J Public Health Manag Pract; 2016; 22(4):E21-8. PubMed ID: 26480282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global strategic partnerships in regenerative medicine.
    French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA
    Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

  • 35. U.S. drug shortages for medications used in adult critical care (2001-2016).
    Mazer-Amirshahi M; Goyal M; Umar SA; Fox ER; Zocchi M; Hawley KL; Pines JM
    J Crit Care; 2017 Oct; 41():283-288. PubMed ID: 28622641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronze Award: A Private-Public Partnership to Deliver Population-Level Integrated Care to Low-Income Seniors in Pennsylvania. SUSTAIN (SUpporting Seniors receiving Treatment And INtervention), Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, and the Department of Aging, Commonwealth of Pennsylvania, Harrisburg.
    Streim JE; Oslin DW
    Psychiatr Serv; 2015 Oct; 66(10):e12-4. PubMed ID: 26423172
    [No Abstract]   [Full Text] [Related]  

  • 39. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring a public-private partnership new-graduate physiotherapy recruitment program: a qualitative study.
    Schmidt D; Dmytryk N
    Aust J Rural Health; 2014 Dec; 22(6):334-9. PubMed ID: 25495629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.